Clinical research decisions are only as sound as the records supporting them, and that soundness begins with data integrity: the degree of confidence that clinical research data remain complete, consistent, accurate, and reliable throughout the data lifecycle.
Earning that confidence requires ALCOA+, a practical framework for creating and maintaining trustworthy records across paper and electronic systems.
This guide recounts the history of ALCOA, defines each ALCOA+ data integrity principle, connects the framework to regulatory expectations, and walks through real-world documentation examples. It also identifies common mistakes and practical ways to embed data integrity into routine research operations.
What is ALCOA in clinical research?
ALCOA stands for “attributable, legible, contemporaneous, original, and accurate.” Together, these five principles describe the qualities records should possess so another person can understand who performed an activity, what occurred, and when it happened.
The ALCOA principles apply broadly across regulated documentation, including:
- Source records.
- Case report forms.
- Laboratory records.
- Electronic data capture systems.
- Audit trails.
- Data corrections.
Many quality and compliance teams use ALCOA clinical research standards as a shared reference point when designing source documentation and preparing for monitoring visits or inspections.
What is the history of ALCOA?
ALCOA emerged in the early 1990s, when Food and Drug Administration (FDA) compliance officer Stan W. Woollen introduced the acronym as a memory aid for training Good Laboratory Practice (GLP) inspectors. The expectations behind the acronym reflected concerns already common in regulated pharmaceutical and clinical research environments: that a record’s value depends on more than whether it contains the correct final number. Reviewers must also be able to determine where the information came from and whether it changed over time.
The framework became widely used because it translates broad recordkeeping expectations into five memorable documentation principles.
As clinical research increasingly adopted electronic systems, decentralized workflows, and complex data transfers, organizations needed to account for additional dimensions of data integrity. A record might satisfy the original five ALCOA principles but still be unreliable if relevant information was missing or authorized reviewers couldn’t retrieve it.
Regulators formalized these four additions in the European Medicines Agency’s 2010 Reflection Paper on Electronic Source Data in Clinical Trials, an approach later echoed in World Health Organization and UK Medicines and Healthcare products Regulatory Agency guidance.
What is ALCOA+?
ALCOA+ retains the original five ALCOA principles and adds “complete, consistent, enduring, and available” to reflect the full lifecycle of regulated records:
- Attributable: The record shows who or what performed the activity and when.
- Legible: The information remains readable and understandable.
- Contemporaneous: The activity is recorded when it occurs or as soon as reasonably possible afterward.
- Original: The record is the first capture of the information or a verified, certified copy.
- Accurate: The information correctly reflects what occurred.
- Complete: All relevant information and record history are retained.
- Consistent: Records follow a logical chronology and use consistent formats and processes.
- Enduring: Records are preserved in a durable, controlled medium.
- Available: Records can be retrieved and reviewed when needed.
Some organizations also discuss traceability or other supporting concepts when describing data integrity. However, the nine principles above form the primary ALCOA+ framework.
Attributable
An attributable record identifies the person or system responsible for an activity and indicates when it was performed. Signatures and audit-trail entries provide the context needed to determine a record’s origin.
For example, a research coordinator should sign or electronically authenticate a source note using an individual account. A shared login prevents reviewers from determining who entered or changed the information and therefore weakens attribution.
Legible
Legible information remains readable, understandable, and interpretable throughout its required retention period. The principle encompasses more than handwriting. Records should also use understandable terminology and preserve necessary context.
A paper note, for example, should be written clearly in permanent ink. An electronic record should use standardized fields and produce readable exports that preserve the meaning of the underlying data.
Contemporaneous
Contemporaneous documentation is created when an activity occurs or as soon as reasonably possible afterward. Recording information near the time of the event reduces reliance on memory and helps establish an accurate chronology.
For example, a participant’s vital signs should be entered during the visit rather than reconstructed from memory several days later. If immediate documentation isn’t possible, the subsequent entry should clearly reflect when it was recorded and when the underlying activity occurred.
Original
An original record is the first capture of information or a verified, certified copy that preserves the original content and context.
An electronic source record may serve as the original when information is entered directly into a validated system at the point of care.
This distinction matters most when data move between paper and electronic systems during a study. (For more on this, explore how paper and electronic source data can meet ALCOA expectations.)
Accurate
Accurate information correctly reflects what occurred and is supported by appropriate checks and controls.
For example, a recorded medication dose may be verified against the source. If the reviewer identifies an entry error, the record should be corrected so the original entry remains visible and the change is documented.
Complete
A complete record retains all relevant data, changes, repeat measurements, and supporting information. It shouldn’t present only the final result when earlier entries or contextual details are necessary to understand how that result was reached.
For example, a corrected record should include the initial entry, the correction, the reason when it isn’t otherwise apparent, and the associated audit trail.
Consistent
Consistent records follow a logical chronology and use aligned formats, terminology, and processes.
For example, visit dates, signatures, timestamps, and data transfers should align across source records and the clinical trial system. Differences may be legitimate, but unexplained discrepancies can make the study difficult to reconstruct.
Enduring
Enduring data are maintained in a durable medium that protects them from loss, alteration, or deterioration throughout the required retention period.
A controlled electronic repository with backups, retention controls, and appropriate access protections supports this principle. Temporary notes and unsecured local files don’t.
Available
Available records can be retrieved and reviewed when needed for monitoring, audits, inspections, or participant safety decisions. Availability should extend throughout the applicable retention period, not merely while a study is active.
For example, authorized reviewers should be able to access complete source records and relevant audit trails without relying on undocumented workarounds or obsolete technology.
Why does FDA reference ALCOA and data integrity principles?
ALCOA functions as a framework for operationalizing regulatory expectations for reliable, traceable, and trustworthy records, rather than as a standalone regulation itself.
Its principles align with expectations related to Good Clinical Practice (GCP), source documentation, electronic record controls, audit trails, record retention, and inspection readiness. These alignments help demonstrate that clinical research activities occurred as represented and that the resulting data are credible.
Documentation quality allows FDA and other reviewers to assess questions such as:
- Can study activities be reconstructed?
- Can data be traced to their source?
- Is the sequence of events clear?
- Are changes transparent and attributable?
- Were records protected and retained appropriately?
- Is the submitted information supported by reliable evidence?
Simply referring to ALCOA in a policy or training program doesn’t demonstrate compliance. Organizations must support ALCOA data integrity through effective procedures, trained personnel, appropriate oversight, and fit-for-purpose systems.
Why does data integrity matter in clinical research?
Strong data integrity practices support four core clinical research objectives:
- Participant protection: Reliable records help research teams identify safety signals, make informed medical decisions, and communicate new risk information.
- Scientific validity: Complete and accurate data support credible analyses and conclusions about an investigational product’s safety and effectiveness.
- Regulatory confidence: Traceable records allow monitors, auditors, institutional review boards (IRBs), sponsors, and regulators to verify that the study was conducted as represented.
- Operational efficiency: Strong documentation can reduce avoidable queries, repeat work, reconciliation problems, and delays during monitoring or inspection preparation.
Practical ALCOA+ examples in clinical research
The following scenarios show how ALCOA+ principles work together in everyday research activities.
Documenting a participant visit
During a participant visit, the coordinator records study activities as they occur, uses an authenticated identity, and completes all required fields. If information is unavailable or a procedure isn’t performed, the coordinator documents that status rather than leaving an unexplained blank.
Correcting a source data error
A coordinator notices that a laboratory report was transcribed into the source record with the wrong unit of measure. The coordinator makes the correction without obscuring the original entry, adds the current date and an attributable signature or electronic authentication, and records the reason if it isn’t otherwise apparent.
Recording an adverse event
An adverse event record should capture relevant details such as onset date, severity, relatedness, actions taken, outcome, and follow-up. The information should remain complete and consistent across source records and safety reports.
Using electronic source data
An electronic source system should support unique user access, audit trails, controlled corrections, backups, and readable retrieval. Its functionality should be validated as appropriate for its intended use.
Handling a late entry
If information must be documented after the activity occurred, the entry should be identified as late, use the current date, and reference the date of the original activity.
The entry shouldn’t be backdated or framed to suggest the documentation happened in real time.
Common ALCOA+ mistakes in clinical research
Common documentation practices that can undermine ALCOA+ data integrity include:
- Backdating records or signing documentation as though it was completed earlier.
- Using shared accounts, copied signatures, or undocumented system identities.
- Recording observations on temporary notes and discarding them after transferring selected information.
- Leaving blank fields without indicating whether information was not collected, not applicable, unknown, or unavailable.
- Overwriting or obscuring original entries instead of preserving a transparent correction history.
- Entering data long after an activity without identifying the documentation as a late entry.
- Assuming an electronic system automatically ensures data integrity.
- Failing to retain metadata, audit trails, attachments, or prior versions needed to reconstruct a record.
How to apply ALCOA+ principles in everyday research operations
Organizations can translate ALCOA+ from a theoretical framework into consistent practice through coordinated measures.
Establish clear documentation expectations
Translate each principle into standard operating procedures, work instructions, source documentation standards, and role-specific expectations.
Use realistic training scenarios
Training should address situations staff actually encounter, including corrections, late entries, missing data, electronic signatures, and source-to-system transcription.
Configure systems to support data integrity
Electronic systems should provide individual accounts, role-based permissions, audit trails, backups, retention controls, and readable exports.
Define the original source
Before data collection begins, determine which record or system will serve as the original source for each type of information. This step is especially important when information moves across devices and platforms.
Review performance and address trends
Monitoring, quality reviews, and trend analysis can help organizations identify recurring documentation problems before they become systemic. Corrective and preventive actions (CAPAs) should address the root causes of those problems.
Treat data integrity as a shared responsibility
Investigators, research sites, sponsors, contract research organizations (CROs), vendors, data managers, and quality teams all influence the reliability of study records.
Frequently asked questions about ALCOA+
Embedding data integrity throughout the clinical trial lifecycle
ALCOA+ gives research organizations a practical framework for producing records that are trustworthy and suitable for clinical and regulatory decision-making.
Consistent data integrity depends on daily behaviors, well-designed processes, effective oversight, and reliable systems, not documentation cleanup immediately before an audit or inspection. As clinical research becomes more digital and interconnected, organizations should embed ALCOA+ expectations across the full trial lifecycle and among every party responsible for study data.
